Farag Kameel D.

Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗

Lifetime net: $0

Positions by company

Reported holding is the most recent post-transaction share count on a Table I row.

Every company this insider has reported trading in, with the value bought and sold at each and the date they last traded.
Ticker	Company	Bought	Sold	Net	Shares held	Last trade
AKTX	Akari Therapeutics Plc	$0	$0	$0	23,309	Aug 17
BIVI	Biovie INC.	$0	$0	$0	—	Jan 5

Akari Therapeutics Plc

Bought

Sold

Held

23,309

Biovie INC.

Bought

Sold

Held

—

How quickly this filer reports. Section 16 allows two business days from the transaction.

2 of 7 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 11 business days late.

Form 4 filings made after the two-business-day deadline, with the transaction date, the filing date and the number of business days between them.
Traded	Filed	Company	Past deadline	Largest line	Source
Jul 16	Aug 4	AKTXAkari Therapeutics Plc	11days	$13K	Filing ↗
Jan 5	Jan 8	BIVIBiovie INC.	1day	—	Filing ↗

Akari Therapeutics Plc

The 15 most recent Form 4 transactions.

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Ticker	Company	Type	Shares	Price	Value	Δ Own	Filing
Aug 17	AKTX	Akari Therapeutics Plc	AGRANT	1,728	$7.52	$13K	+8.0%	Open the original filing on SEC.gov
Jul 16	AKTX	Akari Therapeutics Plc	AGRANT	1,130	$11.50	$13K	+5.5%	Open the original filing on SEC.gov
Jun 24